The safety of beta-blocker use in chronic obstructive pulmonary disease patients with respiratory failure in the intensive care unit

Table 3 ICU outcome data of the two groups (case: beta-blockers, control: non-beta-blockers)

Outcome	Case, n = 74	Control, n = 114	p
Application of NIV, n (%)	67 (90.5)	87 (76.3)	0.013
NIV duration, day	6 (3–7)	5 (2–8)	0.84
Application of IMV, n (%)	25 (33.8)	40 (35.1)	0.85
IMV duration, day, median (quartile 1–3)	2 (1–5)	5 (2–9)	0.10
Length of ICU stay, median (quartile 1–3)	6 (4–10)	7 (4–10)	0.69
ICU mortality, %	17.6	15.8	0.75
Hospital mortality, %	18.9	19.3	0.95
30 day mortality, %	20.0 (12/60)	11.0 (10/91)	0.13

ICU, intensive care unit; IMV, Invasive mechanical ventilation, NIV, noninvasive mechanical ventilation.

ISSN: 2049-6958